oncaspar
les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,
pallrywyn 20 f. tab
charak - ayurvedic preparation - f. tab - 20
ywy postnatal care capsules
wan yeen trading sdn. bhd. - salvia miltiorrhiza; leonurus heterophyllus; boswellia carterii; prunus persica; cordyceps sinensis; commiphora myrrha -
ywy menstrual care capsules
wan yeen trading sdn. bhd. - leonurus heterophyllus; salvia miltiorrhiza; angelica sinensis; rehmannia glutinosa; lycium barbarum; paeonia lactiflora (alba); ligusticum chuanxiong -
ywy pearl plus capsules
wan yeen trading sdn. bhd. - hyriopsis cumingii; tremella fuciformis -
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile
citra-lock 46.7% catheter lock solution 5ml vials
syner-med (pharmaceutical products) ltd -
citra-lock s 30% catheter lock solution for injection 2.5ml pre-filled syringes
syner-med (pharmaceutical products) ltd -
citra-lock s 46.7% catheter lock solution for injection 2.5ml pre-filled syringes
syner-med (pharmaceutical products) ltd -